You just read:

Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1

News provided by

Shionogi-ViiV Healthcare LLC

26 Jul, 2012, 21:30 BST